XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation
9 Months Ended
Mar. 28, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-based Compensation

Stock-based Compensation

We maintain an omnibus stock incentive plan. This plan provides for the granting of stock options, shares of restricted stock and stock appreciation rights. As of March 28, 2021, the Board of Directors had designated 2 million shares of common stock available for the grant of awards under the plan. Remaining shares available to be granted under the plan as of March 28, 2021 were 219,084. Awards that expire or are canceled without delivery of shares become available for re-issuance under the plan. We issue new shares of common stock to satisfy stock option exercises.

Nonqualified and incentive stock options and shares of restricted stock have been granted to our officers, outside directors and specified associates under our stock incentive plan. Stock options granted under the plan may not be issued with an exercise price less than the fair market value of the common stock on the date the option is granted. Stock options become exercisable as determined at the date of grant by the Compensation Committee of the Board of Directors. The options expire 10 years after the grant date unless an earlier expiration date is set at the time of grant. The options vest 1 to 4 years after the date of grant as determined by the Compensation Committee of the Board of Directors. Shares of restricted stock granted under the plan are subject to vesting criteria determined by the Compensation Committee of the Board of Directors at the time the shares are granted and have a minimum vesting period of one year from the date of grant. Unvested restricted shares granted have voting rights, regardless of whether the shares are vested or unvested, but only have the right to receive cash dividends after such shares become vested. Restricted stock grants vest 1 to 5 years after the date of grant as determined by the Compensation Committee of the Board of Directors.

The fair value of each stock option grant was estimated as of the date of grant using the Black-Scholes pricing model. The fair value of each restricted stock grant was based on the market price of the underlying common stock as of the date of grant. The resulting compensation cost for fixed awards with graded vesting schedules is amortized on a straight line basis over the vesting period for the entire award.


 

A summary of stock option activity under our stock incentive plan for the nine months ended March 28, 2021 follows:

 

 

 

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Remaining

Contractual

Term (years)

 

 

Aggregate

Intrinsic

Value

(in thousands)

 

Outstanding, June 28, 2020

 

 

90,860

 

 

$

35.88

 

 

 

 

 

 

 

 

 

Exercised

 

 

18,236

 

 

$

28.85

 

 

 

 

 

 

 

 

 

Outstanding, March 28, 2021

 

 

72,624

 

 

$

37.65

 

 

 

1.7

 

 

$

819

 

Exercisable, March 28, 2021

 

 

72,624

 

 

$

37.65

 

 

 

1.7

 

 

$

819

 

 

The intrinsic value of stock options exercised and the fair value of stock options that vested during the three and nine month periods presented below were as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

 

March 28,

2021

 

 

March 29,

2020

 

 

March 28,

2021

 

 

March 29,

2020

 

 

Intrinsic Value of Options Exercised

 

$

555

 

 

$

 

 

$

555

 

 

$

120

 

 

Fair Value of Stock Options Vesting

 

$

 

 

$

 

 

$

 

 

$

 

 

 

No options were granted during the nine month periods ended March 28, 2021 or March 29, 2020.  

 

A summary of restricted stock activity under our stock incentive plan for the nine months ended March 28, 2021 follows:

 

 

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

Nonvested Balance, June 28, 2020

 

 

69,394

 

 

$

30.59

 

Granted

 

 

48,300

 

 

$

21.20

 

Vested

 

 

(34,669

)

 

$

34.95

 

Forfeited

 

 

(1,050

)

 

$

22.84

 

Nonvested Balance, March 28, 2021

 

 

81,975

 

 

$

23.31

 

 

As of March 28, 2021, all compensation cost related to outstanding stock options granted under our omnibus stock incentive plan has been recognized. As of March 28, 2021, there was approximately $1.0 million of total unrecognized compensation cost related to unvested restricted stock grants outstanding under the plan. This cost is expected to be recognized over a remaining weighted average period of 1 year. Total unrecognized compensation cost will be adjusted for any future changes in estimated and actual forfeitures of awards granted under our omnibus stock incentive plan.